IITRI NEWS
NEWS
We are ready to answer your questions and provide guidance.
News
Visit Our Virology Team’s Poster Presentation at ASV!
This weekend, members of our virology team will be attending the American Society for Virology's Annual Meeting in Athens, Georgia. Albert will be presenting the poster "Contact Transmission Model of SARS-CoV-2 Delta Infection in Hamsters" during Poster Session I on...
Service Spotlight: Drug-Resistant Pathogen Studies
The recent outbreaks of pan-resistant Candida auris and the alarming effects on health care facilities have brought to the forefront the challenges of combating drug-resistant or antimicrobial resistant pathogens. Since the typical treatment for Candida infections and...
Will We See You At SOT 2023?
Next month we'll be back at the 62nd Annual Meeting for the Society of Toxicology (Mar 19-23) at the Nashville Music City Center. You can find us in the Expo hall at Booth #602 from 9am - 4:30pm Mon-Wed. Click here for the map! We look forward to speaking with...
IITRI Highlights: SARS-CoV-2 Publication and New DABTs
IITRI is proud to share recent accomplishments from two of our technical divisions. Several members of our Microbiology and Molecular Biology Division authored a recent publication entitled "Characterization of Three Variants of SARS-CoV-2 In Vivo Shows...
Sponsor News: Ascletis U.S. IND Filing of Antiviral ASC10 for MPX
IITRI is happy to share the promising news of one of our Sponsors, Ascletis Pharma, Inc. They just announced the Investigational New Drug (IND) application of ASC10, an oral antiviral drug candidate targeting viral polymerase of monkeypox virus, has been filed with...
We’ll be at the American College of Toxicology Meeting from Nov 13-16!
Next month, we'll be back at the American College of Toxicology 43rd Annual Meeting (Nov 13-16) at the Gaylord Rockies right outside Denver, Colorado. You can find us in the exhibit hall on Monday and Tuesday at Booth #103 close to the entrance! We look...
Partner News: NCI Project Team Award for Inhaled COVID-19 Candidate APN-01
IITRI is happy to share the good news from our collaboration with the National Cancer Institute (NCI) on their program focusing on an inhaled drug against SARS-CoV-2. Our team here at IITRI was contracted to perform toxicology studies for their drug...
Sponsor News: Antiviral activity of Ascletis’ candidates against SARS-CoV-2
IITRI is happy to share the promising news of one of our Sponsors, Ascletis Pharma, Inc. Our team here at IITRI was contracted to perform in vitro testing of their drug candidates for antiviral effects against multiple strains of SARS-CoV-2 as well as cytotoxicity....
See You Soon at the SOT Annual Meeting in San Diego!
We're excited to be attending the 61st Annual Meeting and ToxExpo (March 27-31, 2022) in sunny San Diego after two years of delayed and virtual meetings. You can find us at the Expo at Booth #2307 from March 28-30 in the Exhibit Hall (ground level) from 9am- 4:30pm....
Service Spotlight : Vaccine Challenge and Toxicology Studies
August is National Immunization Awareness Month (NIAM) which serves as reminder of the importance of vaccination for people of all ages. We're proud to play a role in the development and testing of vaccines here at IITRI. IITRI has decades of experience conducting...
Recent Comments